Larry Biegelsen

Johnson & Johnson (NYSE: JNJ) reported a 3% growth in net sales to $24.02 billion, surpassing the consensus estimate of $23.81 billion, and a 4.4% growth in adjusted earnings to $2.59 per share, beating Street expectations of $2.57 per share. Raymond James On Johnson & Johnson: Analyst...

Intuitive Surgical, Inc. (NASDAQ: ISRG) shares are sharply higher Friday following strong quarterly results. The Analysts Morgan Stanley analyst David Lewis reiterated an Overweight rating and $620 price target for Intuitive Surgical. (See his track record here) Wells Fargo analyst Larry Biegelsen...

Johnson & Johnson (NYSE: JNJ) stock was on the rise Wednesday following better-than-expected third-quarter earnings and guidance, but analysts are mostly leery of boosting recommendations in light of a string of legal challenges the company faces. The Analysts Morgan Stanley’s...

Johnson & Johnson (NYSE: JNJ) announced a $20.4-million agreement Wednesday with the Ohio counties of Cuyahoga and Summit to settle an opioid lawsuit with the state, removing the company from federal multidistrict litigation. The Analysts Credit Suisse analyst Matt Miksic reiterated an...

Large-cap medtech company Medtronic PLC (NYSE: MDT) reported strong first-quarter results Tuesday, sending its shares to a 52-week high. The Analysts Wells Fargo Securities analyst Larry Biegelsen maintained an Outperform rating on Medtronic and $120 price target. BMO Capital Markets...

Johnson & Johnson (NYSE: JNJ) shares are down 2% since the company reported a second-quarter earnings beat on Tuesday morning. Johnson & Johnson reported a 42% increase in net profit in the quarter. Revenue of $20.56 billion was down 1.3% from a year ago but also topped consensus analyst...

Medtronic PLC (NYSE: MDT) has earned a bullish review from Wells Fargo Securities, which premised its optimistic outlook on the company's growth prospects. The Analyst Larry Biegelsen upgraded Medtronic from Market Perform to Outperform and increased the price target from $100 to $...

Medical technology and orthopedic implant company Stryker Corporation (NYSE: SYK) reported an earnings beat Tuesday, and three sell-side analysts remain bullish on the stock. Stryker reported quarterly earnings of $1.88 per share, beating the consensus estimate of $1.84 and up about 12...